Cite
CX-5461 sensitizes DNA damage repair-proficient castrate-resistant prostate cancer to PARP inhibition.
MLA
Lawrence M.G., et al. CX-5461 Sensitizes DNA Damage Repair-Proficient Castrate-Resistant Prostate Cancer to PARP Inhibition. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305136638&authtype=sso&custid=ns315887.
APA
Lawrence M.G., Porter L.H., Choo N., Pook D., Grummet J.P., Pezaro C.J., Sandhu S., Ramm S., Luu J., Bakshi A., Goode D.L., Sanij E., Pearson R.B., Hannan R.D., Simpson K.J., Taylor R.A., Risbridger G.P., & Furic L. (2021). CX-5461 sensitizes DNA damage repair-proficient castrate-resistant prostate cancer to PARP inhibition.
Chicago
Lawrence M.G., Porter L.H., Choo N., Pook D., Grummet J.P., Pezaro C.J., Sandhu S., et al. 2021. “CX-5461 Sensitizes DNA Damage Repair-Proficient Castrate-Resistant Prostate Cancer to PARP Inhibition.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305136638&authtype=sso&custid=ns315887.